Ivermectin in Parasitic Infections: Human Applications
Ivermectin is a broad-spectrum antiparasitic medication widely used in the treatment of several parasitic infections in humans. Originally derived from avermectins produced by Streptomyces avermitilis, ivermectin works by binding to glutamate-gated chloride ion channels in nerve and muscle cells of parasites, leading to paralysis and death of the organism.
Clinically Iverheal 12mg is most notably used in the management of onchocerciasis (river blindness) and lymphatic filariasis, both caused by filarial worms transmitted through insect bites. It is also effective against strongyloidiasis, a potentially life-threatening infection caused by Strongyloides stercoralis, and is sometimes used in cases of scabies and pediculosis (lice infestations) where conventional treatments fail.
The drug is usually administered orally, with dosing adjusted according to body weight and infection type. Ivermectin’s safety profile is generally favorable, making it suitable for mass drug administration programs in endemic regions. However, certain side effects such as dizziness, itching, or mild gastrointestinal upset may occur, often related to the body’s response to dying parasites rather than the drug itself.
Overall, ivermectin remains a cornerstone in global parasitic disease control, reducing transmission, alleviating symptoms, and improving quality of life for millions in resource-limited settings.
.
